Efficacy and safety of hydroxychloroquine vs chloroquine in acute uncomplicated P. falciparum malaria: a systematic review and meta-analysis

International Journal of Infectious Diseases•2021

Authors

PR Martins-Filho, AAS Santos, JC Tavares, MM Rios, MS Pereira, RL Moreira, JI Forrest, EJ Mills

Hydroxychloroquine

Abstract

Background: Hydroxychloroquine and chloroquine are antimalarial drugs with different safety profiles. We conducted a systematic review and meta-analysis to compare their efficacy and safety in treating acute uncomplicated Plasmodium falciparum malaria.

Read Full Paper

Related Publications

Effect of early treatment with hydroxychloroquine or lopinavir and ritonavir on risk of hospitalization among patients with COVID-19: the TOGETHER randomized clinical trial

JAMA Network Open • 2021

COVID-19

Hydroxychloroquine

The rise and fall of hydroxychloroquine for the treatment and prevention of COVID-19

Expert Review of Anti-infective Therapy • 2021

COVID-19

Hydroxychloroquine